Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of BGN 1.06 billion. The enterprise value is 1.53 billion.

Market Cap	1.06B
Enterprise Value	1.53B

Important Dates

The last earnings date was Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Sopharma AD has 166.36 million shares outstanding. The number of shares has increased by 19.22% in one year.

Current Share Class	n/a
Shares Outstanding	166.36M
Shares Change (YoY)	+19.22%
Shares Change (QoQ)	-23.80%
Owned by Insiders (%)	10.18%
Owned by Institutions (%)	0.63%
Float	38.38M

Valuation Ratios

The trailing PE ratio is 13.62.

PE Ratio	13.62
Forward PE	n/a
PS Ratio	0.50
PB Ratio	1.25
P/TBV Ratio	1.89
P/FCF Ratio	24.62
P/OCF Ratio	13.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 35.48.

EV / Earnings	19.71
EV / Sales	0.72
EV / EBITDA	9.63
EV / EBIT	15.04
EV / FCF	35.48

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.57.

Current Ratio	1.17
Quick Ratio	0.52
Debt / Equity	0.57
Debt / EBITDA	3.59
Debt / FCF	11.10
Interest Coverage	5.93

Financial Efficiency

Return on equity (ROE) is 10.28% and return on invested capital (ROIC) is 3.92%.

Return on Equity (ROE)	10.28%
Return on Assets (ROA)	2.88%
Return on Invested Capital (ROIC)	3.92%
Return on Capital Employed (ROCE)	7.10%
Revenue Per Employee	382,117
Profits Per Employee	13,904
Employee Count	5,599
Asset Turnover	1.29
Inventory Turnover	4.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.32% in the last 52 weeks. The beta is -0.24, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.24
52-Week Price Change	-1.32%
50-Day Moving Average	5.80
200-Day Moving Average	5.82
Relative Strength Index (RSI)	69.98
Average Volume (20 Days)	3,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of BGN 2.14 billion and earned 77.85 million in profits. Earnings per share was 0.47.

Revenue	2.14B
Gross Profit	464.42M
Operating Income	76.28M
Pretax Income	91.46M
Net Income	77.85M
EBITDA	112.85M
EBIT	76.28M
Earnings Per Share (EPS)	0.47

Full Income Statement

Balance Sheet

The company has 36.07 million in cash and 480.26 million in debt, giving a net cash position of -444.18 million or -2.67 per share.

Cash & Cash Equivalents	36.07M
Total Debt	480.26M
Net Cash	-444.18M
Net Cash Per Share	-2.67
Equity (Book Value)	849.36M
Book Value Per Share	4.97
Working Capital	124.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 76.59 million and capital expenditures -33.34 million, giving a free cash flow of 43.25 million.

Operating Cash Flow	76.59M
Capital Expenditures	-33.34M
Free Cash Flow	43.25M
FCF Per Share	0.26

Full Cash Flow Statement

Margins

Gross margin is 21.71%, with operating and profit margins of 3.57% and 3.64%.

Gross Margin	21.71%
Operating Margin	3.57%
Pretax Margin	4.27%
Profit Margin	3.64%
EBITDA Margin	5.27%
EBIT Margin	3.57%
FCF Margin	2.02%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 2.34%.

Dividend Per Share	0.15
Dividend Yield	2.34%
Dividend Growth (YoY)	-89.00%
Years of Dividend Growth	n/a
Payout Ratio	216.37%
Buyback Yield	-19.22%
Shareholder Yield	-16.87%
Earnings Yield	7.31%
FCF Yield	4.06%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 2.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.56
Piotroski F-Score	n/a